CClinicalTrials.gg
CompletedNCT01644383Updated Aug 18, 2016

Meaning of Life in HIV-infected Youths

An interventional study of logotherapy in Meaning of Life, sponsored by The HIV Netherlands Australia Thailand Research Collaboration. Completed at 1 site in Thailand. Open to participants aged 16 Years to 24 Years. Per ClinicalTrials.gov, last updated 2016-08-18.

Sponsored by The HIV Netherlands Australia Thailand Research Collaboration · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
16 Years to 24 Years
Sex
All
01

Study summary

Logotherapy has never been evaluated in HIV-infected teenagers. In this study, we will evaluate the meaning of life by using The Purpose in Life Test and the affect of logotherapy in HIV infected youth at HIV-NAT, Thai Red Cross AIDS Research Centre and King Chulalongkorn Memorial Hospital.

Read the detailed description

In the HAART era, HIV infected children can live longer and will grow up to become teenagers. However, some may develop psychosocial problems because they have lost family members, experienced poverty, social discrimination etc. Being a normal teenager is tough and is the most complex period of his/her life. This is the period when most teenagers will find their identity and reasons for living. Therefore it is believed that interventions may help HIV-infected teenagers better deal with life. For this study, logotherapy, a therapy that will help a person to discover his/her purpose in life, live meaningful life, and attain self-esteem was used. The success of the intervention was evaluated by using The Purpose in Life Test.

02

Conditions studied

  • Meaning of Life

Keywords

  • meaning of life
  • logotherapy
  • HIV-infected teenagers
  • adherence
03

In context

Lead sponsor

The HIV Netherlands Australia Thailand Research Collaboration is the lead sponsor of 59 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age 16-24 years
  2. HIV seropositive
  3. HIV disclosed
  4. Understand Thai language
  5. Parent signed written informed consent

Exclusion criteria

Exclusion Criteria:

  1. Mental or psychological disorder or having active suicidal idea or attempt
  2. Having no permanent address
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Treatment arm (logotherapy)

    Participants in Arm I will attend the logotherapy group sessions by the trained psychologist for 4 visits (see Table II, III). The number of participants in group sessions will be 20 participants per group.

    Behavioral: logotherapy

  • No intervention
    Control arm (general health education)

    Participants in Arm II will attend the routine health education by the nurse. The number of participants in group session will be 20 participants per group.

Interventions

  • Behaviorallogotherapy

    Logotherapy is therapy during which the interaction between the therapist and the client centres on the topic of meaning. The problems that the clients experience are presented to the client as inseparable parts of his everyday life. The client is then challenged to discover his/her meaning and to take responsibility in facing up to his/her problem. This approach is aimed at helping the client to deal and understand what his /her existences entail.

06

What researchers measure

Primary outcomes

  1. PIL score

    Change of PIL score at baseline and follow up visit between the two arms

    Time frame: week 48

Secondary outcomes

  1. QOL

    Time frame: 48 weeks

07

Study locations

1 site
  • HIV-NAT, the Thai Red Cross AIDS Research Centre
    Bangkok, 10330, Thailand
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01644383
Lead sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators
Chulalongkorn University, Pediatric department, Chulalongkorn University, Bangkok, Thailand, SEARCH Research Foundation, Wayne State University, University of Minnesota
Responsible party
Sponsor
First posted
Jul 19, 2012
Start date
Feb 2011
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Aug 18, 2016

Study contacts

Arunya Tuicomepee, PhD
principal investigator · Chulalongkorn University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion